Patent · US Expired

Chimeric interleukin 5-receptor/immunoglobulin polypeptides

US5712121A · kind A · utility

13Cited by

1References

27Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Rene Robert Devos · Welwyn Garden City, GB
Walter Fiers · Laarne, BE
Jose van der Heyden · Munte, BE
Geert Plaetinck · Merelbeke, BE
Jan Tavernier · Balegem, BE

Key dates

Filing date	Apr 13, 1995
Grant date	Jan 27, 1998
Priority date	—
Expiry date	Apr 13, 2015

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.-and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy--or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.